←back to thread

322 points atomroflbomber | 1 comments | | HN request time: 0s | source
Show context
rowinofwin ◴[] No.36985095[source]
Wow, sounds like a game changer. A totally different mechanism with almost no effect on healthy cells and it can be used as an adjunct to other chemotherapies? I mean, if it pans out, wow, that would be amazing. I remember reading about how with HIV if you have 1 drug it works for a while but evolves out from under you, 2 drugs extends this time, and a third just flattens it so much there isnt enough popation to mutate away. In the same way adding this as an adjunct could prevent the drift which can happen to some cancers when under selection from a chemo drug. Exciting times.
replies(1): >>36995226 #
1. adamredwoods ◴[] No.36995226[source]
That's the hope. I think Keytruda, aka Pembrolizumab, has also been a game-changer. It can run with other forms of treatment as well.

I hope we're entering a new epoch. The number of people I've met who've lost loved ones too early.

That dragon, cancer. https://en.wikipedia.org/wiki/That_Dragon,_Cancer